Login to Your Account



Search

Search results

Pharma: Clinic Roundup

• UCB SA , of Brussels, Belgium, reported post-hoc analyses of pivotal trials of Neupro (rotigotine transdermal system) in patients with restless legs syndrome (RLS)/Willis Ekbom disease, showing improvements with rotigotine vs. placebo in most of ...

BioWorld Today - Staff - 2012-04-26 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Dompe Group , of Milan, said it started a phase Ib/II study to assess the safety and potential efficacy of recombinant human nerve growth factor (rhNGF) eye drops in two doses vs. placebo. (BioWorld-Today-2014-04-04) ...

BioWorld Today - Staff - 2014-04-04 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Bayer HealthCare Pharmaceuticals Inc. , of Whippany, N.J., began enrollment in a trial studying Xofigo (radium Ra 223 dichloride) injection in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mil ...

BioWorld Today - Staff - 2014-04-03 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Forest Laboratories Inc ., of New York, and Gedeon Richter Plc , of Budapest, Hungary, reported positive top-line results from a global, randomized, placebo-controlled, fixed-dose, eight-week phase IIb trial evaluating the efficacy and safety of c ...

BioWorld Today - Staff - 2014-04-01 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Pfizer Inc. , of New York, and Bristol-Myers Squibb Co. , also of New York, said results of a pre-specified subanalysis of the phase III ARISTOTLE trial assessing the effect of blood pressure control on outcomes as well as the treatment effect of ...

BioWorld Today - Staff - 2014-03-28 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Pfizer Inc ., of New York, reported top-line results from a phase IIIB study evaluating the 24-month efficacy of Genotropin (somatropin) on the height in small-for-gestational-age children 24-30 months old. (BioWorld-Today-2014-03-27) ...

BioWorld Today - Staff - 2014-03-27 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Pfizer Inc. , of New York, reported that PROFILE 1014, a phase III study testing anaplastic lymphoma kinase (ALK) inhibitor Xalkori (crizotinib) met its primary objective of significantly prolonging progression-free survival in previously untreated p ...

BioWorld Today - Staff - 2014-03-26 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Abbvie Inc. , of North Chicago, Ill., said a pivotal phase III trial that will evaluate the use of Humira (adalimumab) as a treatment for fingernail psoriasis in patients with moderate to severe chronic plaque psoriasis, has been initiated. ...

BioWorld Today - Staff - 2014-03-21 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Novo Nordisk A/S , of Bagsvaerd, Denmark, reported positive results from pathfinder2, the first phase III trial with long-acting recombinant factor VIII, N8-GP (turoctocog alfa pegol) for hemophilia A patients. (BioWorld-Today-2014-03-20) ...

BioWorld Today - Staff - 2014-03-20 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Ipsen SA , of Paris, reported phase IIa results showing that Dysport was associated with a mean reduction from baseline of urinary incontinence episodes greater than 75 percent, 12 weeks after injection, regardless of how the drug was administered in ...

BioWorld Today - Staff - 2014-03-19 00:00 - 0 comments - 0 attachments